CHELSEA KELLAMS: Open Payments
NPI 1063996254 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,616 in 116 payments from 19 companies in 2025. Trend: 2023 $1,584 · 2024 $2,915 · 2025 $2,616
Food & beverage: $2,516Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $828 |
| ABBVIE INC. | 26 | $424 |
| Novo Nordisk Inc | 11 | $279 |
| GlaxoSmithKline, LLC. | 11 | $195 |
| PFIZER INC. | 13 | $149 |
| Astellas Pharma US Inc | 3 | $144 |
| Exact Sciences Corporation | 6 | $114 |
| Axsome Therapeutics, Inc. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
Products named: BREZTRI, UBRELVY, TRELEGY ELLIPTA, Ozempic, NURTEC ODT, VRAYLAR, Cologuard Collection Kit, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
